Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Nan, Yue Min ^a   Kong, Ling Bo ^a   Ren, Wei Guang ^a   Wang, Rong Qi ^a   Du, Jing Hua ^a   Li, Wen Cong ^a   Zhao, Su Xian ^a   Zhang, Yu Guo ^a   Wu, Wen Juan ^a   Di, Hai Ling ^a   Li, Ya ^a   Yu, Jun ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Animal experiment; Ethanol; Fibrosis; Liver; Peroxisome proliferator activated receptor alpha

Indexed keywords

ADIPONECTIN; ALCOHOL; CARBON TETRACHLORIDE; GELATINASE A; GELATINASE B; HEME OXYGENASE 1; INTERLEUKIN 10; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PIRINIXIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; PIECEMEAL NECROSIS; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION;

ADIPONECTIN; ANIMALS; ANTICHOLESTEREMIC AGENTS; CARBON TETRACHLORIDE; CYTOKINES; ETHANOL; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HEPATIC STELLATE CELLS; HEPATOCYTES; INTERLEUKIN-10; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOPONTIN; PPAR ALPHA; PYRIMIDINES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 84873264109     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-11     Document Type: Article

References (44)

1. Role of oxidative stress in alcohol-induced liver injury. Cederbaum AI, Lu Y, Wu D, Arch Toxicol 2009 83 519 548 10.1007/s00204-009-0432-0 19448996
2. Ethanol metabolism, cirrhosis and alcoholism. Lieber CS, Clin Chim Acta 1997 257 59 84 10.1016/S0009-8981(96)06434-0 9028626 (Pubitemid 27055895)
3. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Cubero FJ, Nieto N, Hepatology 2008 48 2027 2039 10.1002/hep.22592 19003881
4. TGF-beta1 gene silencing for treating liver fibrosis. Cheng K, Yang N, Mahato RI, Mol Pharm 2009 6 772 779 10.1021/mp9000469 19388665
5. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced hepatic steatohepatitis in mice. Kong L, Ren W, Li W, Zhao S, Mi H, Wang R, Zhang Y, Wu W, Nan Y, Yu J, Lipids Health Dis 2011 10 246 10.1186/1476-511X-10-246 22208561
6. Pathological mechanisms in carbon tetracholoride hepatotoxicity. Brattin WJ, Glende EA Jr, Recknage lRO, J Free Radic Biol Med 1985 1 27 38 10.1016/0748-5514(85)90026-1 3915301 (Pubitemid 16104819)
7. Inhibiting Proteasomal Degradation of Microsomal Triglyceride Transfer Protein Prevents CCl4-induced Steatosis. Pan X, Hussain FN, Iqbal J, Feuerman MH, Hussain MM, J Biol Chem 2007 282 17078 17089 10.1074/jbc.M701742200 17405876 (Pubitemid 47093224)
8. Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status. Ismail RS, El-Megeid AA, Abdel-Moemin AR, Ger Med Sci 2009 7 oc05 19675745
9. Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat. Hall PD, Plummer JL, Ilsley AH, Cousins MJ, Hepatology 1991 13 815 819 2029987
10. Liver fibrosis: a dynamic and potentially reversible process. Povero D, Busletta C, Novo E, di Bonzo LV, Cannito S, Paternostro C, Parola M, Histol Histopathol 2010 25 1075 1091 20552556
11. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T, Gut 2006 55 415 424 10.1136/gut.2005.071118 16174657 (Pubitemid 43268283)
12. Intrahepatic gene expression in human alcoholic hepatitis. Seth D, Gorrell MD, Cordoba S, McCaughan GW, Haber PS, J Hepatol 2006 45 306 320 10.1016/j.jhep.2006.04.013 16797773
13. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, Moles A, Mann DA, Bobola N, Sharrocks AD, Thomson BJ, Zaitoun AM, Irving WL, Guha IN, Hanley NA, Hanley KP, Hepatology 2012 56 1108 1116 10.1002/hep.25758 22488688
14. Osteopontin expression in the liver with severe perisinusoidal fibrosis: Autopsy case of Down syndrome with transient myeloproliferative disorder. Tokairin T, Nishikawa Y, Watanabe H, Doi Y, Omori Y, Yoshioka T, Yamamoto Y, Yoshida M, Nishimura T, Li Q, Arai H, Ishida A, Takada G, Enomoto K, Pathol Int 2008 58 64 68 18067644 (Pubitemid 350198311)
15. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N, Hepatology 2012 55 594 608 10.1002/hep.24701 21953216
16. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Lang Q, Liu Q, Xu N, Qian KL, Qi JH, Sun YC, Xiao L, Shi XF, Biochem Biophys Res Commun 2011 409 448 453 10.1016/j.bbrc.2011.05.023 21600192
17. TGF-β1 as possible link between loss of bone mineral density and chronic inflammation. Ehnert S, Baur J, Schmitt A, Neumaier M, Lucke M, Dooley S, Vester H, Wildemann B, Stöckle U, Nussler AK, PLoS One 2010 5 14073 10.1371/journal.pone.0014073 21124921
18. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis. Huang L, Wei MF, Feng JX, Eur J Pediatr Surg 2008 18 224 229 10.1055/s-2008-1038483 18704890
19. A Key Role for Pre-B cell Colony-Enhancing Factor in Experimental Hepatitis. Moschen AR, Gerner R, Schroll A, Fritz T, Kaser A, Tilg H, Hepatology 2011 54 675 686 10.1002/hep.24416 21567435
20. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. Ognjanovic S, J Mol Endocrinol 2001 26 107 117 10.1677/jme.0.0260107 11241162 (Pubitemid 32266186)
21. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R, Tan BK, Punn A, Chen J, Randeva HS, Cardiovasc Res 2008 78 356 365 10.1093/cvr/cvm111 18093986 (Pubitemid 351556097)
22. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Ikeda K, Wakahara T, Wang YQ, Kadoya H, Kawada N, Kaneda K, Hepatology 1999 29 1760 1767 10.1002/hep.510290640 10347119 (Pubitemid 29247050)
23. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP, Benyon RC, Liver Int 2004 24 492 501 10.1111/j.1478-3231.2004.0946.x 15482348 (Pubitemid 40484564)
24. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, Casini A, Hepatology 2005 41 1074 1084 10.1002/hep.20683 15841469 (Pubitemid 40593915)
25. Oxidative stress-related molecules and liver fibrosis. Parola M, Robino G, J Hepatol 2001 35 297 306 10.1016/S0168-8278(01)00142-8 11580156 (Pubitemid 32803489)
26. A Matrix Metalloproteinase-9 Activation Cascade by Hepatic Stellate Cells in Trans-differentiation in the Three-dimensional Extracellular Matrix. Han YP, Yan C, Zhou L, Qin L, Tsukamoto H, J Biol Chem 2007 282 12928 12939 10.1074/jbc.M700554200 17322299 (Pubitemid 47100583)
27. Matrix metalloprotease-9 induces transforming growth factor-β(1) production in airway epithelium via activation of epidermal growth factor receptors. Perng DW, Chang KT, Su KC, Wu YC, Chen CS, Hsu WH, Tsai CM, Lee YC, Life Sci 2011 89 204 212 10.1016/j.lfs.2011.06.008 21718706
28. TGF-beta1-induced PI3K/Akt/NF-kappaB/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts. Zhu X, Wang L, Zhang B, Li J, Dou X, Zhao RC, J Biochem 2011 149 405 414 10.1093/jb/mvr016 21288887
29. Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Thakur V, Pritchard MT, McMullen MR, Nagy LE, Am J Physiol 2006 290 998 1007
30. Hepatic adipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T, Hepatology 2008 48 458 473 10.1002/hep.22365 18666257
31. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA, Am J Pathol 2005 166 1655 1669 10.1016/S0002-9440(10)62476-5 15920151 (Pubitemid 40734389)
32. PPARgamma is essential for protection against nonalcoholic steatohepatitis. Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, Sung JJ, Yu J, Gene Ther 2010 17 790 798 10.1038/gt.2010.41 20376096
33. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. Mandal P, Pritchard MT, Nagy LE, World J Gastroenterol 2010 16 1330 1336 10.3748/wjg.v16.i11.1330 20238399
34. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10. Zheng WD, Zhang LJ, Shi MN, Chen ZX, Chen YX, Huang YH, Wang XZ, World J Gastroenterol 2005 11 1753 1758 15793858
35. Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells. Zhang LJ, Chen YX, Chen ZX, Huang YH, Yu JP, Wang XZ, World J Gastroenterol 2004 10 2574 2579 15300910
36. Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Zhang LJ, Zheng WD, Chen YX, Huang YH, Chen ZX, Zhang SJ, Shi MN, Wang XZ, Hepatogastroenterology 2007 54 2092 2098 18251166
37. Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats. Zhang LJ, Yu JP, Li D, Huang YH, Chen ZX, Wang XZ, World J Gastroenterol 2004 10 77 81 14695773 (Pubitemid 38071982)
38. Increased toxin-induced liver injury and fibrosis in interleukin-6- deficient mice. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R, Hepatology 2000 31 149 159 10.1002/hep.510310123 10613740 (Pubitemid 30033701)
39. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. Wang XZ, Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ, World J Gastroenterol 2004 10 2706 2710 15309723
40. Interleukin-10-Mediated Heme Oxygenase 1-Induced Underlying Mechanism in Inflammatory Down-Regulation by Norfloxacin in Cirrhosis. Gómez-Hurtado I, Zapater P, Bellot P, Pascual S, Pérez-Mateo M, Such J, Francés R, Hepatology 2011 53 935 944 10.1002/hep.24102 21374664
41. Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. Drechsler Y, Dolganiuc A, Norkina O, Romics L, Li W, Kodys K, Bach FH, Mandrekar P, Szabo G, J Immunol 2006 177 2592 2600 16888021 (Pubitemid 44201018)
42. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice. Wang RQ, Nan YM, Wu WJ, Kong LB, Han F, Zhao SX, Kong L, Yu J, Lipids Health Dis 2011 10 31 10.1186/1476-511X-10-31 21314960
43. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R, Am J Gastroenterol 2008 103 2747 2756 10.1111/j.1572-0241.2008.02104.x 18721242
44. Guideline for management of alcoholic liver disease: a update and revised edition. The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association, Zhonghua Ganzangbing Zazhi 2010 18 167 170